Sponsor Pipeline

Abcentra Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06927739 Focused Orticumab Research for Treating Inflammation in Coronary Arteries Acute Coronary Syndromes Recruiting
Disease Areas
Heart Disease (1) Coronary Artery Disease (1)
Get alerts when Abcentra's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free